<DOC>
	<DOCNO>NCT01819714</DOCNO>
	<brief_summary>The main objective study evaluate effect 3 month `` Snoezelen-type '' multi-sensory care session NeuroPsychiatric Inventory Questionnaire ( NPI-Q ) score patient Alzheimer's-type neurodegenerative disease .</brief_summary>
	<brief_title>Sensory Support Care Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease</brief_title>
	<detailed_description>The secondary objective study study follow element relationship implementation `` Snoezelen-type '' multi-sensory care strategy patient Alzheimer's-type neurodegenerative disease : A. evaluate effect NPI-Q score 1 month , 6 month 12 month . B. evaluate effect quality life ( questionnaire QOL-AD ) 0 12 month . C. ass change `` aggressive behavior '' subsection Cohen-Mansfield Agitation Inventory ( CMAI ) questionnaire 0 , 1 , 3 , 6 12 month . D. assess change drug consumption ( anxiolytic , antidepressant , hypnotic , neuroleptic ) study period</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Neurodegenerative Diseases</mesh_term>
	<criteria>The patient 's legal representative must give his/her inform sign consent ( patient he/she judge competent ) The patient must insure beneficiary health insurance plan Alzheimer'stype neurodegenerative pathology The patient live participate center &gt; 2 month The patient 's legal representative refuse sign consent ( patient he/she judge competent ) It impossible correctly inform patient 's legal representative The patient already Snoezelentherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Snoezelen</keyword>
	<keyword>Multi-sensorial care session</keyword>
	<keyword>Alzheimer's-type neurodegenerative disease</keyword>
	<keyword>Dementia</keyword>
</DOC>